faculty photo

James F Morley, M.D., Ph.D.

Assistant Professor of Neurology at the Veteran's Administration Medical Center
Associate Director for Research, Parkinson's Disease Research, Education and Clinical Center. Philadelphia VA Medical Center
Staff Neurologist, Philadelphia VA Medical Center
Department: Neurology

Contact information
Parkinson's Disease Research, Education and Clinical Center
3900 Woodland Ave.
Mail Stop 127
Philadelphia, PA 19104
Office: 215-823-5934
Wharton School, University of Pennsylvania, 1996.
Northwestern University, 2003.
Feinberg School of Medicine, Northwestern University, 2005.
Post-Graduate Training
Intern in Internal Medicine, University of Pennsylvania, 2005-2006.
Resident in Neurology, University of Pennsylvania, 2006-2009.
Fellow in Movement Disorders, University of Pennsylvania, 2009-2011.
American Board of Psychiatry and Neurology, 2009.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Sneha Mantri; Michelle E. Fullard; John E. Duda; James F. Morley: Physical Activity in Early Parkinson Disease. Journal of Parkinson's Disease 8 (1): 107-111, 2018.

James F. Morley, Abigail Cohen, Laura Silveira-Moriyama, Andrew J. Lees, David R. Williams, Regina Katzenschlager, Christopher Hawkes, Julie P. Adelman, Daniel Weintraub, Richard L. Doty and John E. Duda. : Optimizing olfactory testing for the diagnosis of Parkinson’s disease: item analysis of the University of Pennsylvania Smell Identification Test. npj Parkinson's Disease 15(4): 2, Jan 2018.

James F. Morley, Gang Cheng, Jacob G. Dubroff, Stephanie Wood, Jayne R. Wilkinson and John E. Duda: Olfactory impairment predicts underlying dopaminergic deficit in presumed drug-induced parkinsonism Movement Disorders: Clinical Practice 4(4): 603, 2017 Notes: e-pub before print DOI 10.1002/mdc3.12458.

Michelle Fullard; Baochan Tran; Sharon X. Xie; Christie Scordia; Carly Linder; Rachael Purri; Daniel Weintraub; John E. Duda; Lama Chahine; James F. Morley: Olfactory impairment predicts cognitive decline in early Parkinson's disease Parkinsonism & Related Disorders 25: 45-51, Apr 2016 Notes:

Kara Pigott, Jacqueline Rick, Sharon X. Xie, Howard Hurtig, Alice Chen-Plotkin, John Duda, James F. Morley, Lama Chahine, Nabila Dahodwala1, Rizwan S. Akhtar, Andrew Siderowf, John Trojanowski, Daniel Weintraub: Long-term outcomes for Parkinson's disease patients with normal cognition. Neurology 85(15): 1276-82, Oct 2015.

Amy M. Hellman, Shital P. Shah, Stephanie M. Pawlowski, John E. Duda and James F. Morley: Continuous Non-Invasive Monitoring to Detect Covert Autonomic Dysfunction in Parkinson’s Disease. Parkinsonism and Related Disorders 21 (7): 723-8, 2015.

Morley JF, Pawlowski S, Pantelyat A, Maina I and Duda JE: Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism Parkinsonism & Related Disorders 20(7): 738-42, July 2014.

James F. Morley and John E. Duda: Use of hyposmia and other non-motor symptoms to distinguish between drug-induced Parkinsonism and Parkinson's disease Journal of Parkinson's Disease 4(4): 169-73, 2014.

Joshua M. Milber, Joseph V. Noorigian, James F. Morley, Helen Petrovitch, Lon White, G. Webster Ross, and John E. Duda: Lewy pathology is not the first sign of degeneration in vulnerable neurons in PD. Neurology 79(24): 2307-14, Dec 2012.

Morley, J.F., S.X. Xie, H.I. Hurtig, M.B. Stern, A. Colcher, S. Horn, N. Dahodwala, J.E. Duda, D. Weintraub, A.S. Chen-Plotkin, V. Van Deerlin, D. Falcone & A. Siderowf: Genetic influences on cognitive decline in Parkinson disease. Movement Disorders 27(4): 512-8, April 2012 Notes: selected as featured Editor's Choice article.

back to top
Last updated: 02/29/2020
The Trustees of the University of Pennsylvania

© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.